Compare EVO & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | CAC |
|---|---|---|
| Founded | 1993 | 1875 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 923.2M |
| IPO Year | N/A | 1996 |
| Metric | EVO | CAC |
|---|---|---|
| Price | $1.96 | $54.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $47.00 |
| AVG Volume (30 Days) | 44.2K | ★ 100.5K |
| Earning Date | 04-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.51% |
| EPS Growth | N/A | ★ 6.08 |
| EPS | N/A | ★ 1.29 |
| Revenue | N/A | ★ $41,739,000.00 |
| Revenue This Year | $1.37 | $19.15 |
| Revenue Next Year | $10.05 | $6.05 |
| P/E Ratio | ★ N/A | $41.55 |
| Revenue Growth | N/A | ★ 16.96 |
| 52 Week Low | $1.94 | $35.00 |
| 52 Week High | $4.42 | $56.23 |
| Indicator | EVO | CAC |
|---|---|---|
| Relative Strength Index (RSI) | 25.35 | 58.28 |
| Support Level | N/A | $52.15 |
| Resistance Level | $3.36 | $56.10 |
| Average True Range (ATR) | 0.10 | 1.36 |
| MACD | -0.05 | -0.15 |
| Stochastic Oscillator | 1.02 | 67.89 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.